Hydroxypropyl Methyl Cellulose structure
|
Common Name | Hydroxypropyl Methyl Cellulose | ||
---|---|---|---|---|
CAS Number | 9004-65-3 | Molecular Weight | 478.49 | |
Density | 1.39 | Boiling Point | N/A | |
Molecular Formula | C18H38O14 | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | N/A |
Use of Hydroxypropyl Methyl CelluloseHypromellose is a water-soluble hydrophilic, non-ionic cellulose ether used to form swellable-soluble matrices. |
Name | Hypromellose |
---|---|
Synonym | More Synonyms |
Description | Hypromellose is a water-soluble hydrophilic, non-ionic cellulose ether used to form swellable-soluble matrices. |
---|---|
Related Catalog | |
In Vitro | Hypromellose provides the release of a drug in a controlled manner, effectively increasing the duration of release of a drug to prolong its therapeutic effect[1]. Hypromellose (hydroxypropylmethylcellulose) has been used in sustained-release pharmaceutical products for many years. When used in matrix tablets, these polymers hydrate on contact with water to produce a viscous gel barrier within and surrounding the tablet. The properties of hypromellose that affect the rate of drug release include the rate of diffusion of water into the dry polymer, the rate of hypromellose hydration and gel formation, the viscosity of the hydrated hypromellose and rate of hypromellose gel erosion[2]. |
In Vivo | Punctal occlusion using hypromellose 2% is a low-cost and safe additional treatment for dry eye. Fluorescein and rose bengal staining tests show that there was a significant reduction in signs after occlusion using hypromellose[3]. Hypromellose is effective in improving the blood glucose metabolism and suppressing oxidative stress in mice fed with a high fat diet. The antihyperglycemic and antioxidative effects of hypromellose could be partly attributed to the regulation of hepatic glucose-regulating enzyme activities and activation of the hepatic and erythrocyte antioxidant enzymes. Hypromellose may be useful as biomaterials in the development of functional food or as therapeutic agents against high fat-induced hyperglycemia and oxidative stress[4]. |
References |
[2]. Braund R, et al. Hypromellose films for the delivery of growth factors for wound healing. |
Density | 1.39 |
---|---|
Molecular Formula | C18H38O14 |
Molecular Weight | 478.49 |
Appearance of Characters | powder |
Stability | Stable. Solid is combustible, incompatible with strong oxidizing agents. |
Water Solubility | H2O: 50 mg/mL, clear to very faintly turbid, faintly yellow | SOLUBLE |
Compounded preparations with nystatin for oral and oromucosal administration.
Acta Pol. Pharm. 70(4) , 759-62, (2013) Therapy of oral, esophageal and gastrointestinal candidiasis is still a common problem that can be solved by an administration of antimycotics. Major disadvantage of registered commercial antifungal m... |
|
Curcumin amorphous solid dispersions: the influence of intra and intermolecular bonding on physical stability.
Pharm. Dev. Technol. 19(8) , 976-86, (2014) We have investigated the physical stability of amorphous curcumin dispersions and the role of curcumin-polymer intermolecular interactions in delaying crystallization. Curcumin is an interesting model... |
|
ROI-SCAVENGING ENZYME ACTIVITIES AS TOXICITY BIOMARKERS IN THREE SPECIES OF MARINE MICROALGAE EXPOSED TO MODEL CONTAMINANTS (COPPER, IRGAROL AND ATRAZINE)
Ecotoxicol. Environ. Saf. 104 , 294-301, (2014) There is a need to develop efficient tools to prevent damage to marine ecosystems due to pollution. Since microalgae play a key role in marine ecosystems, they are considered potentially useful for qu... |
2-Hydroxypropyl 2,3,6-tris-O-(2-hydroxypropyl)-4-O-[2,3,4,6-tetrakis-O-(2-hydroxypropyl)-β-D-glucopyranosyl]-β-D-glucopyranoside - methyl 2,3,6-tri-O-methyl-4-O-(2,3,4,6-tetra-O-methyl-β-D-gl ucopyranosyl)-β-D-glucopyranoside (1:1) |
Hydroxypropyl methyl cellulose |
EINECS 220-971-6 |
MHPC |
Hydroxypropyl methylcellulose |
MFCD00131360 |
E464 |
β-D-Glucopyranoside, 2-hydroxypropyl 2,3,6-tris-O-(2-hydroxypropyl)-4-O-[2,3,4,6-tetrakis-O-(2-hydroxypropyl)-β-D-glucopyranosyl]-, compd. with β-D-glucopyranoside, methyl 2,3,6-tri-O-methyl- 4-O-(2,3,4,6-tetra-O-methyl-β-D-glucopyranosyl)- (1:1) |
HPMC |